|
Volumn 6, Issue 11, 2000, Pages 1220-
|
AIDS vaccine advance
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
HYBRID PROTEIN;
IMMUNOGLOBULIN G;
INTERLEUKIN 2;
VIRUS ENVELOPE PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CYTOTOXIC T LYMPHOCYTE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
LYMPHOCYTE DIFFERENTIATION;
LYMPHOCYTE PROLIFERATION;
NOTE;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
VACCINATION;
VACCINE PRODUCTION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AIDS VACCINES;
GENE PRODUCTS, GAG;
HUMANS;
SIMIAN IMMUNODEFICIENCY VIRUS;
T-LYMPHOCYTES, CYTOTOXIC;
VACCINES, DNA;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
|
EID: 0033678529
PISSN: 10788956
EISSN: None
Source Type: Journal
DOI: 10.1038/81318 Document Type: Note |
Times cited : (1)
|
References (0)
|